Outcomes of etravirine-based antiretroviral treatment in treatment-experienced children and adolescents living with HIV in Europe and Thailand.

Publication

Outcomes of etravirine-based antiretroviral treatment in treatment-experienced children and adolescents living with HIV in Europe and Thailand.

Journal Paper/Review - Jun 1, 2022

European Pregnancy And Paediatric Infections Cohort Collaboration Eppicc, Lyons Alex, Thompson Lindsay, Chappell Elizabeth, Ene Luminita, Galli Luisa, Goetghebuer Tessa, Jourdain Gonzague, Noguera-Julian Antoni, Kahlert Christian, Königs Christoph, Kosalaraksa Pope, Lumbiganon Pagakrong, Marczynska Magdalena, Marques Laura, Navarro Marissa Luisa, Naver Lars, Okhonskaia Liubov, Prata Filipa, Puthanakit Thanyawee, Ramos Jose T, Samarina Anna, Thorne Claire, Voronin Evgeny, Turkova Anna, Giaquinto Carlo, Judd Ali, Collins Intira Jeannie

Citation

European Pregnancy And Paediatric Infections Cohort Collaboration Eppicc, Lyons A, Thompson L, Chappell E, Ene L, Galli L, Goetghebuer T, Jourdain G, Noguera-Julian A, Kahlert C, Königs C, Kosalaraksa P, Lumbiganon P, Marczynska M, Marques L, Navarro M, Naver L, Okhonskaia L, Prata F, Puthanakit T, Ramos J, Samarina A, Thorne C, Voronin E, Turkova A, Giaquinto C, Judd A, Collins I. Outcomes of etravirine-based antiretroviral treatment in treatment-experienced children and adolescents living with HIV in Europe and Thailand. Antivir Ther 2022; 27:13596535221092182.

Type

Journal Paper/Review (English)

Journal

Antivir Ther 2022; 27

Publication Date

Jun 1, 2022

Issn Electronic

2040-2058

Pages

13596535221092182

Brief description/objective

Etravirine (ETR) is approved as a component of second or third-line antiretroviral treatment (ART) for children living with HIV. We assessed the outcomes of ETR-based ART in children in routine care in Europe and Thailand.